WallStreetZenWallStreetZen

NASDAQ: LNTH
Lantheus Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LNTH past earnings growth

How has LNTH's earnings growth performed historically?
Company
1,068.29%
Industry
13.52%
Market
71.87%
LNTH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
LNTH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
LNTH's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

LNTH past revenue growth

How has LNTH's revenue growth performed historically?
Company
38.65%
Industry
10.18%
Market
17.2%
LNTH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LNTH's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LNTH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LNTH earnings and revenue history

Current Revenue
$1.3B
Current Earnings
$326.7M
Current Profit Margin
25.2%

LNTH Return on Equity

Current Company
52%
Current Industry
15.4%
Current Market
188%
LNTH's Return on Equity (52%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LNTH announces earnings.

LNTH Return on Assets

Current Company
22.3%
Current Industry
3.4%
LNTH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LNTH Return on Capital Employed

Current Company
29.44%
Current Industry
5.1%
LNTH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LNTH vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LNTH$1.30B$491.01M$326.66M+30.44%+35.21%
PRGO$4.66B$516.70M-$12.70M-0.32%N/A
ALKS$1.66B$356.08M$355.76M+8.74%N/A
ALVO$93.38M-$359.68M-$551.73M+3.09%N/A
PBH$1.13B$16.86M-$80.67M+2.74%N/A
View Top Pharmaceutical Stocks

LNTH earnings dates

Next earnings date
May 2, 2024

Lantheus Holdings Earnings & Revenue FAQ

What were LNTH's earnings last quarter?

On Invalid Date, Lantheus Holdings (NASDAQ: LNTH) reported Q4 2023 earnings per share (EPS) of $1.52, up 187.36% year over year. Total Lantheus Holdings earnings for the quarter were $103.38 million. In the same quarter last year, Lantheus Holdings's earnings per share (EPS) was -$1.74.

If you're new to stock investing, here's how to buy Lantheus Holdings stock.

What was LNTH's earnings growth in the past year?

As of Q2 2024, Lantheus Holdings's earnings has grown 1,068.29% year over year. This is 1,054.78 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 13.52%. Lantheus Holdings's earnings in the past year totalled $326.66 million.

What is LNTH's earnings date?

Lantheus Holdings's earnings date is Invalid Date. Add LNTH to your watchlist to be reminded of LNTH's next earnings announcement.

What was LNTH's revenue last quarter?

On Invalid Date, Lantheus Holdings (NASDAQ: LNTH) reported Q4 2023 revenue of $354.00 million up 34.52% year over year. In the same quarter last year, Lantheus Holdings's revenue was $263.17 million.

What was LNTH's revenue growth in the past year?

As of Q2 2024, Lantheus Holdings's revenue has grown 38.65% year over year. This is 28.46 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Lantheus Holdings's revenue in the past year totalled $1.30 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.